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Two strains of a hitherto-undescribed gram-positive, catalase-negative coccus isolated from human sources
were characterized by phenotypic and molecular taxonomic methods. Comparative 16S rRNA gene sequencing
studies demonstrated that the unknown strains are genealogically identical and constitute a new line close to,
but distinct from, Facklamia hominis. The unknown bacterium was readily distinguished from F. hominis by
biochemical tests and electrophoretic analysis of whole-cell proteins. On the basis of phylogenetic and phe-
notypic evidence, it is proposed that the unknown bacterium be classified as Facklamia ignava sp. nov. The type
strain of Facklamia ignava is CCUG 37419.
It has only been in recent years that clinical microbiologists
have started to fully appreciate the considerable diversity of
the gram-positive, facultatively anaerobic, catalase-negative
cocci encountered in clinical specimens. In addition to previ-
ously unrecognized species within well-established genera
(e.g., Streptococcus), a plethora of organisms belonging to com-
pletely unknown genera, such as Alloiococcus (1), Dolosigranu-
lum (3), Facklamia (5), Globicatella (4), and Helcococcus (6),
have recently been described. Central to the recognition of
these newly discovered organisms within the clinical environ-
ment has been the application of improved diagnostic tools, in
particular the combined use of phenotypic approaches such as
miniaturized biochemical testing and protein profiling and mo-
lecular-based methodologies such as 16S rRNA gene sequenc-
ing. In this article, we report the use of such a polyphasic
taxonomic approach for the characterization of two strains of
a hitherto-unknown gram-positive, catalase-negative coccus
from human sources. On the basis of comparative 16S rRNA
gene sequence analysis and the phenotypic distinctiveness of
the unknown bacterium, a new species, Facklamia ignava, is
described.
Two strains (164-97 and 1440-97) from human sources were
referred to the Centers for Disease Control (Atlanta, Ga.) for
identification. Both strains originated from blood. Strain
164-97 was isolated from an 82-year-old woman who was a
resident of a long-term nursing facility in Canada. The culture
was received from Margurite Lovgren, Streptococcus Refer-
ence Laboratory, Edmonton, Alberta, Canada. The patient
was ambulatory and able to care for all her personal needs. She
was admitted to the hospital with complaints of nausea and
vomiting for the previous 48 h. A diagnosis of pneumonia was
determined after the blood cultures were positive for the iso-
late. The patient was treated with antimicrobial agents and
discharged from the hospital after 2 weeks. Strain 1440-97 was
isolated from an 86-year-old woman living in North Carolina.
The culture was received from Wake Medical Center, Raleigh,
N.C. The only other clinical information available is that the
patient was septic at the time of culture. The cultures have
been deposited in the Culture Collection of the University of
Göteborg (CCUG), Göteberg, Sweden, under accession no.
CCUG 37419 and CCUG 37659, respectively. The strains were
cultured on Columbia agar (Difco, Detroit, Mich.) supple-
mented with 5% horse blood at 37°C. The strains were bio-
chemically characterized by using the API Rapid ID32 Strep
and API ZYM systems according to the manufacturer’s in-
structions (API bioMérieux, Marcy l’Etoile, France). Poly-
acrylamide gel electrophoresis (PAGE) of whole-cell proteins
was performed as described previously (11). For densitometric
analysis normalization and interpretation of protein patterns,
the Gelcompar GCW 3.0 software package (Applied Maths,
Kortrijk, Belgium) was used. The cell wall murein type of each
of the two strains was determined as described by Schleifer and
Kandler (12). The DNA base composition of strain 164-97 was
determined by thermal denaturation as described by Garvie
(9). Phylogenetic studies involved comparative 16S rRNA gene
sequence analysis. A large fragment of the 16S rRNA gene
(corresponding to positions 30 to 1521 of the Escherichia coli
16S rRNA gene) was amplified by PCR using conserved prim-
ers close to the 39 and 59 ends of the gene. The PCR products
were purified by using a Prep-A-Gene kit (Bio-Rad, Hercules,
Calif.) according to the manufacturer’s instructions and di-
rectly sequenced by using a Taq Dye-Deoxy terminator cycle
sequencing kit (Applied Biosystems, Foster City, Calif.) and an
automatic DNA sequencer (model 373A; Applied Biosystems).
The closest known relatives of the new isolates were deter-
mined by performing a database search, using the program
FASTA of the Genetics Computer Group package (7). These
sequences and those of other, related strains were retrieved
from the GenBank or Ribosomal Database Project library and
aligned with the newly determined sequences by using the
program PILEUP (7). The resulting multiple sequence align-
ment was corrected manually, and approximately 100 bases at
the 59 end of the rRNA were omitted from further analyses
because of alignment ambiguities. A continuous stretch of
1,320 bases was used for distance matrix analysis. A distance
matrix was calculated by using the programs PRETTY (7) and
DNADIST (using the Kimura-2 correction parameter) (8). A
phylogenetic tree was constructed according to the neighbor-
joining method with the program NEIGHBOR (8). The sta-
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bility of the groupings was estimated by bootstrap analysis (500
replications), using the programs DNABOOT, DNADIST,
NEIGHBOR, and CONSENSE (8).
Cells of the two isolates from humans were ovoid in shape
and formed pairs and short chains. Both strains were gram-
positive, non-spore-forming, catalase-negative facultative an-
aerobes which were nonhemolytic. The strains did not grow at
10 or 45°C. They resembled each other in hydrolyzing hippu-
rate and producing alanine-phenylalanine-proline arylamidase
and pyroglutamic acid arylamidase. Neither strain produced
arginine dihydrolase, alkaline phosphatase, glycyl-tryptophan
arylamidase, b-glucuronidase, b-glucosidase, a-galactosidase,
b-galactosidase, b-mannosidase, pyrazinamidase, or urease.
Both strains weakly fermented glucose but failed to produce
acid from amygdalin, L-arabinose, D-arabitol, cellobiose, cyclo-
dextrin, inulin, glycogen, lactose, maltose, D-mannose, melibi-
ose, melezitose, mannitol, lactose, pullulan, D-raffinose, D-ri-
bose, sorbitol, sucrose, D-xylose, L-xylose, D-tagatose, and
trehalose. Based on the above characteristics, the unknown
isolates appeared to resemble Facklamia hominis. However,
the unknown bacterium differed significantly from the latter
species in not producing arginine dihydrolase, a-galactosidase,
b-galactosidase, glycyl-tryptophan arylamidase, and urease.
The unidentified bacterium could also be readily distinguished
from other catalase-negative cocci (e.g., Abiotrophia adiacens,
Abiotrophia defectiva, and Globicatella sanguinis) by its rela-
tively asaccharolytic nature. The close phenotypic affinity be-
tween the two clinical isolates was confirmed by PAGE analysis
of whole-cell proteins, in which they formed a quite distinct
cluster. Consistent with the aforementioned biochemical find-
ings, PAGE analysis showed that the unknown bacterium was
phenotypically most similar to, albeit distinct from, F. hominis.
No close phenotypic resemblance to any other catalase-nega-
tive spheroidal organisms studied was shown (Fig. 1). An ex-
amination of the cell wall murein compositions of the two
strains revealed that lysine was the dibasic amino acid and that
the interpeptide bridge was L-Lys–D-Asp (type A4a, according
to the nomenclature of Schleifer and Kandler [12]). This
murein structure is found in several gram-positive, catalase-
negative cocci, including Dolosigranulum pigrum (3), F. hominis
(5), and Lactosphaera pasteurii (10), as well as in some entero-
cocci, lactococci, pediococci, and streptococci (12). The cell
wall type of the unknown coccus is, however, quite distinct
from those of Alloiococcus otitis (1), G. sanguinis (4), Abiotro-
phia defectiva (5), and aerococci (2), all of which possess
murein which is directly cross-linked by lysine (type A1a).
To establish the phylogenetic position of the unknown bac-
terium isolated from humans, the 16S rRNA genes of both
isolates were amplified by PCR and characterized by sequence
analysis. The gene sequences of the two strains were deter-
mined almost completely (.1,400 nucleotides), and pairwise
analysis showed that they were genealogically homogeneous
(100% 16S rRNA sequence similarity). Sequence searches of
the GenBank and Ribosomal Database Project libraries re-
vealed that the unknown coccus from humans was phyloge-
netically most closely associated with the lactic acid group
FIG. 1. Similarity dendogram based on whole-cell protein pattern of F.
ignava sp. nov. and related species. Levels of correlation (top) are expressed as
percentages of similarity for convenience.
FIG. 2. Unrooted tree showing the phylogenetic relationships of F. ignava sp. nov. and some other low-G1C-content gram-positive bacteria. The tree, constructed
by the neighbor-joining method, was based on a comparison of approximately 1,320 nucleotides. Bootstrap values, expressed as a percentage of 500 replications, are
given at branching points. Asterisks indicate sequences obtained from the Institute of Food Research database.
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bacteria (data not shown). The sequences of the nearest rela-
tives of the unknown organism were retrieved and subjected to
comparative analysis to determine the phylogenetic position of
strain 164-97. A tree depicting the phylogenetic affinity of the
unknown coccus within the lactic acid bacteria is shown in Fig.
2. The unknown coccus formed a distinct subline exhibiting a
specific phylogenetic association (approximately 3% 16S rRNA
sequence divergence) with F. hominis. Bootstrap resampling
(value, 100%) showed this association to be statistically highly
significant. The next-nearest relatives of the unknown bacte-
rium were G. sanguinis and Abiotrophia defectiva, which
showed approximately 6 and 8% 16S rRNA sequence diver-
gence, respectively.
From the results of the 16S rRNA gene sequence analysis, it
is clear that the unknown coccus from human sources is a
member of the recently described genus Facklamia (5). Al-
though the phylogenetic association between the unidentified
bacterium and F. hominis is statistically highly significant, a 16S
rRNA sequence divergence of approximately 3% indicates that
the two are closely related, but nevertheless quite separate,
species. Support for the separateness of the unknown bacte-
rium and F. hominis comes from PAGE analysis of whole-cell
proteins. In addition, the two taxa can be readily distinguished
biochemically (Table 1). Based on both phenotypic and phy-
logenetic findings, we consider the unknown coccus to merit
classification as a new species of the genus Facklamia; the
name Facklamia ignava sp. nov. is proposed.
Description of Facklamia ignava sp. nov. Facklamia ignava
(L. fem. adj. ignava, lazy, unreactive) cells are gram positive,
ovoid in shape, and occur in pairs or short chains. Cells are
nonpigmented, nonhemolytic, and nonmotile. Spores are not
produced. Facultatively anaerobic and catalase negative. Grows
in 5% NaCl. Does not grow at 10 or 45°C. Weak acid produc-
tion from glucose. Acid is not produced from amygdalin, L-
arabinose, D-arabitol, cellobiose, cyclodextrin, inulin, glycogen,
lactose, maltose, D-mannose, melibiose, melezitose, mannitol,
lactose, pullulan, D-raffinose, D-ribose, sorbitol, sucrose, D-xy-
lose, L-xylose, D-tagatose, or trehalose. Alanine-phenylalanine-
proline arylamidase and pyroglutamic acid arylamidase are
produced. Arginine dihydrolase, alkaline phosphatase, glycyl-
tryptophan arylamidase, b-glucuronidase, b-glucosidase, a-ga-
lactosidase, b-galactosidase, b-mannosidase, pyrazinamidase,
and urease are not produced. Esculin and gelatin are not
hydrolyzed. Hippurate is hydrolyzed. Voges-Proskauer and in-
dole negative. Nitrate is not reduced. The G1C content of the
DNA is 42 mol%. The cell wall murein type is L-Lys–D-Asp
(A4a). The type strain of F. ignava is CCUG 37419. Isolated
from human blood. Habitat unknown.
Nucleotide sequence accession number. The 16S rRNA gene
sequence of strain 164-97 (CCUG 37419) has been deposited
in GenBank under accession no. Y15716.
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F. ignava sp. nov. F. hominis
Arginine dihydrolase 2 1
a-Galactosidase 2 1
b-Galactosidase 2 1
Pyroglutamic acid arylamidase 1 V
Glycyl-tryptophan arylamidase 2 V
Urease 2 V
a 2, negative; 1, positive; V, variable result.
b Test for the production of the indicated enzyme.
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